Why the study?
Does diuretic treatment increase the risk of coronary events in men with mild hypertension and specific resting ECG abnormalities?
Does diuretic treatment increase the risk of coronary events in men with mild hypertension and specific resting ECG abnormalities?
Reanalysis of The Oslo Study supports MRFIT findings that diuretic treatment in mildly hypertensive men with specific resting ECG abnormalities may be associated with an increased risk of coronary events.
Answers are grounded in this paper and cite their sources.
May warrant caution with diuretics in this ECG subgroup; supports MRFIT but remains hypothesis-generating.
The Multiple Risk Factor Intervention Trial (MRFIT) showed that diuretic treatment of hypertensive men with certain ECG abnormalities at entry was associated with an increased coronary heart disease mortality in the special-intervention group as compared with the usual-care group. Following the same criteria for resting ECG abnormalities as in MRFIT, The Oslo Study trial of mild hypertension has been reanalyzed for similar effects. Although numbers of first coronary events are low in this study (20 cases in the treated group and 13 in the control group), similar trends are present in The Oslo Study. The excess of seven cases of coronary events in the Oslo treatment group can mainly be explained by introduction of the MRFIT ECG-Minnesota codes. (JAMA1984;251:1298-1299)
No takes yet. Share an insight, caveat, or question.
Ingar Holme (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: